David Dulaney
Gastroenterology · Jbsa Ft Sam Houston, TXNPI 1427443456
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $95,589 of the $116,712 with a category attached, or 81.9%. 16 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 29.1% of the total. 2025 is the largest year on record at $84,735, more than ten times the $623 reported in 2019. Among gastroenterology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $694.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$34K
- Regeneron Healthcare Solutions, Inc.$29K
- Sanofi$26K
- Lilly USA, LLC$25K
- Bristol Myers Squibb$859
- AbbVie$802
- plus $1K from 10 others
Across 7 payments — averaging $3995.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$28K
What the payments were for
- Speaking & faculty fees$95,58982%
- Travel & lodging$15,44013%
- Food & beverage$5,6695%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $33,929 |
| Regeneron Healthcare Solutions, Inc. | 35 | $28,943 |
| Sanofi | 19 | $25,956 |
| Lilly USA, LLC | 38 | $25,098 |
| Bristol Myers Squibb | 11 | $859 |
| AbbVie | 11 | $802 |
| Intercept Pharmaceuticals, Inc. | 2 | $238 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $184 |
| Medtronic | 1 | $148 |
| Phathom Pharmaceuticals, Inc. | 2 | $131 |
| Olympus America Inc. | 4 | $125 |
| La Jolla Pharmaceutical Company | 1 | $118 |
| Pfizer | 1 | $81 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| Regeneron | 1 | $32 |
| Merck | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$116,712 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Jbsa Ft Sam Houston
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
- Brooks CashHouston$867K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.